Blog
RSS FeedPosted by Michael Wonder on 07 Sep 2020
AstraZeneca vaccine ‘most likely’ to roll out in the U.K. early next year
7 September 2020 - Rise in U.K. COVID cases is predominantly among younger people, health secretary says. ...
Posted by Michael Wonder on 06 Sep 2020
NICE not supportive of encorafenib for metastatic colorectal cancer
4 September 2020 - NICE has responded to the request of the Department of Health and Social Care to produce ...
Posted by Michael Wonder on 05 Sep 2020
Real world evidence to support payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders
3 September 2020 - There are divergent views on the potential of real world data to inform decisions made by regulators, ...
Posted by Michael Wonder on 03 Sep 2020
Janssen disappointed with second NICE no for Spravato
3 September 2020 - Janssen says it is disappointed with second draft guidance from the National Institute for Health and ...
Posted by Michael Wonder on 02 Sep 2020
NICE terminates yet another assessment of a new cancer medicine
2 September 2020 - This time it is a new medicine for patients with acute myeloid leukaemia. ...
Posted by Michael Wonder on 02 Sep 2020
NICE unable to assess new indication for Soliris
2 September 2020 - NICE was hopeful of being able to assess eculizumab for the treatment of patients with relapsing ...
Posted by Michael Wonder on 02 Sep 2020
Novo launches type 2 diabetes pill in UK after NICE waives review
1 September 2020 - Novo Nordisk has launched its type 2 diabetes pill Rybelsus (semaglutide) in the UK, after cost ...
Posted by Michael Wonder on 02 Sep 2020
NICE green light for immunotherapy Bavencio
2 September 2020 - NICE has now published final guidelines endorsing NHS use of Merck and Pfizer's immunotherapy Bavencio (avelumab) ...
Posted by Michael Wonder on 28 Aug 2020
Kidney cancer charity slams NICE rejection of Keytruda/Inlyta
28 August 2020 - MSD’s Keytruda (pembrolizumab) in combination with Pfizer's Inlyta (axitinib) has been turned down by NICE as ...
Posted by Michael Wonder on 25 Aug 2020
Recruitment begins to fill up to seven non-executive roles on the NICE board
25 August 2020 - Roles will contribute to the development of the NICE’s strategic objectives. ...
Posted by Michael Wonder on 22 Aug 2020
NHS cannabis guidelines challenged in court
18 August 2020 - The parents of a three-year-old boy with severe epilepsy are going to court to mount the ...
Posted by Michael Wonder on 20 Aug 2020
New agreement means NICE recommends combination treatment for some lymphoma patients
20 August 2020 - Hundreds of people with a form of blood cancer will benefit from a new treatment following the ...
Posted by Michael Wonder on 19 Aug 2020
Keeping pace with pharmaceutical innovation: the importance of the NICE methods review
19 August 2020 - The NICE plays a vitally important role in ensuring patients get timely access to new medicines ...
Posted by Michael Wonder on 18 Aug 2020
NICE appoints two directors to key new positions
18 August 2020 - NICE has announced the appointment of two new directors to key positions in newly formed directorates. ...
Posted by Michael Wonder on 17 Aug 2020
Janssen and others have appealed NICE's decision to reject abiraterone acetate for patients with for high risk hormone-sensitive metastatic prostate cancer
17 August 2020 - The appeal panel will convene on 3 September and 4 September to hear oral representations from the ...